Av Joshi

Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective

ABSTRACT Objective: To evaluate the cost of lost productivity in the workplace due to allergic rhinitis compared to other selected medical conditions from an employer perspective. Setting and participants: A total of 8267 US employees at 47 employer locations who volunteered to participate in health/wellness screenings. Measurements: The Work Productivity Short Inventory was used to assess the impact of a predefined group of health conditions on workplace productivity for the previous 12 months. Both absenteeism and presenteeism (lost productivity while at work) were recorded. Costs were calculated using a standard hourly wage. Results: Allergic rhinitis was the most prevalent of the selected conditions; 55% of employees reported experiencing allergic rhinitis symptoms for an average of 52.5 days, were absent 3.6 days per year due to the condition, and were unproductive 2.3 h per workday when experiencing symptoms. The mean total productivity (absenteeism + presenteeism) losses per employee per year were US

Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

593 for allergic rhinitis,

Long-term cost of stroke subtypes among Medicare beneficiaries.

518 for high stress,

Health‐related quality of life and productivity impact in haemophilia patients with inhibitors

277 for migraine,

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression

273 for depression,

Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage

269 for arthritis/rheumatism,

Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors.

248 for anxiety disorder,

Cost and utilization of blood transfusion associated with spinal surgeries in the United States

181 for respiratory infections,

A Retrospective Managed Care Claims Data Analysis of Medication Adherence to Vaginal Estrogen Therapy: Implications for Clinical Practice

105 for hypertension or high blood pressure,

Association of Medication Adherence with Workplace Productivity and Health-Related Quality of Life in Patients with Asthma

95 for diabetes,